Mymetics Corp

(MYMX)

By |

Profile

Mymetics Corp is a US-based vaccine company. It is primarily engaged in developing next-generation vaccines for infectious diseases. The several pipeline vaccine candidates of the company are HIV-1/AIDS, intranasal influenza, malaria, chikungunya, herpes simplex virus (HSV) and the respiratory syncitial virus (RSV) vaccine. The vaccines are designed to induce protection against early transmission and infection, focusing on the mucosal immune response as a first-line defense in combination with humoral and cellular immune responses as a second-line defense, for the development of an effective prophylactic vaccine.

Contact Information

Website: www.mymetics.com
Email: info@mymetics.com
Main Phone: +41 216534535
Address: c/o Mymetics SA
Address 2: Route de la Corniche 4
City / Town: Epalinges
Country: CHE
Postal Code: 1066

Issuer Information

Exchange: OTCQB
CEO: Grant E. Pickering
Employees: 17
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 0.0505 $ -0.0089 (-14.98%)
Last Price 0.0505 Change $ -0.0089 Change % -14.98 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open 0.0592 High 0.0592 Low 0.0505 Prev Close 0.0594
Last Trade Volume 136,587 52 Wk Hi 0.077 52 Wk Low 0.0155
Market Cap 15.3 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 303,757,622.00 EPS (TTM) -0.01 PE Ratio N/A Exchange OTCQB
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 0
Number of Buys 0 0
Number of Sells 0 0
Net Activity 0 0
Last 10 Buys Shares
N/A 0
Last 10 Sell Shares
Jacques Martin 1,000
Christian Rochet 1,000